Veru Inc. - Common Stock (NQ:VERU)

2.220 -0.020 (-0.89%)

Delayed Quote Updated: 12:10 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Veru Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet ↗

November 07, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.

Via Benzinga

Why Veru Stock Is Skyrocketing Today ↗

November 07, 2022

Investors are reacting positively to an FDA briefing document.

Via The Motley Fool

US Stocks Mixed; Dow Rises Over 50 Points ↗

November 07, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday.

Via Benzinga

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know ↗

November 01, 2022

October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the...

Via Benzinga

FDA Schedules Adcomm For Veru's Cancer Drug Repurposed For COVID-19 ↗

September 08, 2022

Via Benzinga

Jim Cramer Says People Are Betting Against Stock Up 84% This Year: It Could Be An 'Up Big, Down Big Situation' ↗

October 18, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Dice Therapeutics Inc (NASDAQ: DICE) as the company is "losing money hand over fist."

Via Benzinga

2 Top Healthcare Stocks Defying the Bear Market ↗

October 09, 2022

Both companies have revenue rolling in today, and they both expect loads more in the near term.

Via The Motley Fool

7 Long-Term Stocks to Buy to Tap Into a Hidden Bull Market ↗

September 30, 2022

These are among the best long-term stocks to buy in Q4. ACLS, AXSM, GBT, GPRO, HCAT, SKLZ, and VERU can make great investments

Via InvestorPlace

7 Momentum Stocks to Buy Now for Extraordinary Gains ↗

September 26, 2022

Momentum stocks aren't as risky as some say, and these winning stocks are strong examples for investors to consider.

Via InvestorPlace

Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session ↗

September 21, 2022

Gainers

Via Benzinga

Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday ↗

September 22, 2022

Gainers

Via Benzinga

Here's How Much $1000 Invested In Veru 5 Years Ago Would Be Worth Today ↗

September 20, 2022

Veru (NASDAQ:VERU) has outperformed the market over the past 5 years by 29.62% on an annualized basis producing an average annual return of 38.73%. Currently, Veru has a market capitalization of...

Via Benzinga

Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday ↗

September 20, 2022

Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.

Via Benzinga

Kroger, DocuSign And Other Big Gainers From Friday ↗

September 12, 2022

U.S. stocks closed higher with the Nasdaq Composite surging 250 points on Friday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session ↗

September 19, 2022

Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.

Via Benzinga

Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session ↗

September 07, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.

Via Benzinga

Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday ↗

September 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...

Via Benzinga

$100 Invested In Veru 5 Years Ago Would Be Worth This Much Today ↗

September 02, 2022

Veru (NASDAQ:VERU) has outperformed the market over the past 5 years by 47.35% on an annualized basis producing an average annual return of 57.29%. Currently, Veru has a market capitalization of $1.19...

Via Benzinga

Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday ↗

September 08, 2022

Gainers

Via Benzinga

Jim Cramer Is Staying Away From This Stock, Says It's The 'Best One Of A Bad Neighborhood' ↗

August 23, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said ChargePoint Holdings, Inc.

Via Benzinga

Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket ↗

August 22, 2022

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public...

Via Benzinga

Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday ↗

August 31, 2022

Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float.

Via Benzinga

Signify Health And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

August 22, 2022

Via Benzinga

Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session ↗

August 30, 2022

Gainers NewAge, Inc. (NASDAQ: NBEV) rose 54.4% to $0.3220.

Via Benzinga

Bed Bath & Beyond, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday ↗

August 18, 2022

Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 23.3% to $17.71 following a Form 144 filing by RC Ventures, which suggested the firm proposed to sell 7.78 million common shares and certain call options....

Via Benzinga

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday ↗

August 19, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.

Via Benzinga

Dow Jumps Over 200 Points; Crude Oil Falls Sharply ↗

August 16, 2022

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 200 points on Tuesday.

Via Benzinga

Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

August 18, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66.

Via Benzinga

U.S. Stocks Trade Mixed; Dow Rises 75 Points ↗

August 16, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 75 points on Tuesday.

Via Benzinga

Investors Benefit as Healthtech Comes Into Focus (VERU, APDN, TOMDF, DNA, SYBX)

August 16, 2022

Via AB Newswire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.